Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-01-07
1997-04-01
Rories, Charles C. P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 536 231, 536 243, 536 2431, 536 2432, 536 2433, 536 245, 536 251, A61K 4800, C12A 168, C12N 510, C07H 2104
Patent
active
056165641
ABSTRACT:
The invention provides methods and materials for antisense oligonucleotide therapy against active pathogenic infection by drug resistant or drug sensitive pathogens, including Plasmodium falciparum.
REFERENCES:
patent: 4806463 (1989-02-01), Goodchild et al.
R. Barker et al. PNAS (Jan. '96) 93:514-8.
A. Storey et al. Nucleic Acids Research, vol. 19 (15) ('91) pp. 4109-4114.
J. Holt et al. PNAS, vol. 83 (Jul. 1986) pp. 4784-4798.
M. Cooney et al. Science, vol. 241 (Jul. 22, 1988) pp. 456-459.
C. H el ene et al. Biochimie, vol. 67 ('85) pp. 777-783.
L. Miller et al. Science, vol. 264, (24 jun. '94) pp. 1878-1883.
C. Stein et al. Science, vol. 261 (20 Aug. '93) pp. 1004-1012.
R. Weiss, Science News, vol. 139 (Feb. 16, 1991) pp. 108-109.
W. Marshall et al. Science, vol. 259 (Mar. 12, 1993) pp. 1564-1570.
D. Tidd, Anticancer Res., vol. 10 ('90) pp. 1169-1182.
W. James Antiviral Chem. & Chemotherapy, vol. 2(4)('91) pp. 191-214.
G. Snousnov Mol. Biochem. Parasitology, vol. 58 ('93) pp. 283-292.
P. Westermann et al. Biomed., Bochim. Acta, vol. 48 #1 (1989) pp. 85-93.
P. Verspieren et al. Gene, vol. 61 ('87) pp. 307-315.
T. Le Doan et al. Bulletin of Cancer, vol. 76 ('89) pp. 849-852.
E. Wickstrom, J. Biochem. & Biophys. Methods, vol. 13 ('86) pp. 97-102.
G. Butcher Parasitology, vol. 98 ('89) pp. 315-327.
Ghosh et al. Nucleic Acids Res., vol 21 #24 ('93) pp. 5761-5766.
Uhlmann, E. et al. Chemical Reviews (Jun. 1990) 90: 544-584.
Trager and Jensen, Science 193, 673-675 (1976).
Desjardins et al., Antimicrobial Agents and Chemotherapy 16, 710-718 (1979).
Chulay et al., Experimental Parasitology 55, 138-146 (1983).
Lambros and Vanderburg, J. of Parasitology. 65, 418-420 (1979).
Bitonti et al., Science 242, 1301-1303 (1988).
Martin et al., Science 235, 899-901 (1987).
Holder et al., Nature 317, 270-273 (1985).
Hadley et al., Ann. Rev. Microbial. 40, 451-477 (1986).
Queen et al., Antimicrobial Agents and Chemotherapy 34, 1393-1398 (1990).
Ferone et al., Molecular Pharmacolgy 5, 49-59 (1969).
Hitchings and Burchell, Advances in Enzymology, 27, 417-468 (1967).
Peterson et al., Proc. Natl. Acad. Sci. U.S.A. 85, 9114-9118 (1988).
Shanzer et al., Proc. Natl. Acad. Sci. U.S.A. 88, 6585-6589 (1991).
Zamecnik and Stephenson, Proc. Natl. Acad. Sci. U.S.A. 75, 280-284 (1978).
Stephenson and Zamecnik, Proc. Natl. Acad. Sci. U.S.A. 75, 285-288 (1978).
Zamecnik et al., Proc. Natl. Acad. Sci. U.S.A. 83, 4143-4146 (1986).
Matsukura et al., Proc. Natl. Acad. Sci. U.S.A. 84, 7706-7710 (1987).
Agrawal et al., Proc. Natl. Acad. Sci. U.S.A. 85, 7079-7084 (1987).
Sarin et al., Proc. Natl. Acad. Sci. U.S.A. 85, 7448-7451 (1988).
Bzik et al., Proc. Natl. Acad. Sci. U.S.A. 84, 8360-8364 (1987).
Sartorius and Franklin, Nucleic Acids Res. 19, 1613-1618 (1991).
Webster et al., Pharmacological Basis of Therapeutics, 954-959 (1990).
Kouni, Biochemical Pharmacology 41, 815-820 (1991).
Agrawal et al., Proc. Natl. Acad. Sci. U.S.A. 86, 7790-7794 (1989).
Agrawal, Prospects for Antisense Nuclei Acid Therapy of Cancer and Aids (1990).
Uhlmann and Peyman, Chemical Reviews 90, 543 (1990).
Hughes et al., Mol. and Biochem. Parasitology 34, 155-166 (1989).
Verspieren et al., Nucleic Acids Res. 18, 4711-4717 (1990).
Tanabe et al., J. Mol. Biol. 195, 273-287 (1987).
Simons et al., Nature 359, 67-70 (1992).
Rapaport et al., Proc. Natl. Acad. Sci. USA 89, 8577-8580 (1992).
Sartorius and Franklin, Parasitology Today 7, 90-93 (1991).
Dix et al., J. Cell Biochem. 41, Supp. O, p. 133 (1989).
Rapaport Eliezer
Zamecnik Paul C.
Greenfield Michael S.
Rories Charles C. P.
Worcester Foundation for Biomedical Research, Inc.
LandOfFree
Antiparasitic oligonucleotides active against drug resistant mal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiparasitic oligonucleotides active against drug resistant mal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiparasitic oligonucleotides active against drug resistant mal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538939